RFK Jr.'s Opening Statement: Reforming HHS for Healthier America

Reforming the Department of Health and Human Services (HHS)

• 🎯 HHS aims to make America healthy again by focusing on the chronic disease epidemic and delivering more efficient services.
• 💰 The goal is to achieve more with less, cutting costs for taxpayers while maintaining compassion and responsibility.
• 🇺🇸 The U.S. spends significantly more on healthcare than comparable nations without better health outcomes, indicating structural issues.

Strategic Budget Priorities

• 🏥 Funding will shift from bureaucracy to direct impact, preserving legacy programs like Medicare and Medicaid.
• 🩺 Prioritizing access to primary care for 83 million Americans, with a focus on Native American and Alaskan communities, including protecting IHS funding and granting tribal autonomy.
• 🤝 Consolidating programs to tackle mental health and addiction, aggressively combating the opioid crisis with a focus on synthetic drugs like fentanyl.

Enhancing Public Health and Research

• 🍎 Emphasizing healthy eating and lifestyles, with a focus on Head Start programs and supporting initiatives like cell and gene therapy for sickle cell anemia.
• 🔬 Equipping the FDA to expand food safety efforts and funding cutting-edge research at the NIH while cutting risky or non-essential studies, including ending gain-of-function experiments and research based on radical gender ideology.
• 📊 Returning the CDC to core missions of disease tracking and outbreak investigation while cutting waste.

Modernization and Trust Rebuilding

• 🚫 Eliminating DEI funding and redirecting resources toward real poverty reduction and meaningful action for communities of color.
• 🤖 Strengthening cybersecurity and health IT by leveraging AI for efficient and secure healthcare data management.
• ✨ Rebuilding public trust through transparency and public service, creating an honest, science-driven HHS accountable to the public.
• 🧠 Addressing the crisis in Alzheimer's research, highlighting potential corruption at the NIH that has derailed progress on amyloid plaque hypotheses.